BioSpace News Archive

Data is part of Genentech’s MORPHEUS umbrella program and covers patients with resistant/refractory NSCLC treated with ciforadenant in combination with atezolizumab

Initial data from the Phase 1b part of the LIO-1 trial of lucitanib combined with Opdivo® (nivolumab) in advanced metastatic solid tumors identify a recommended Phase 2 dose and show promising signs of antitumor activity

78% overall response rate (ORR) and median progression-free survival (PFS) of 36.8 months demonstrate durable response in expanded data set of 175 adults and children

MYR Pharmaceuticals, a German biotechnology company focused on the development and commercialization of therapeutics for the treatment of chronic hepatitis B and D, is pleased to announce that HEPCLUDEX® has successfully launched in Germany, France and Austria.

InnoCare Pharmaceuticals, a clinical stage biopharmaceutical company committed to discovering, developing, and commercializing innovative medicines for the treatment of cancer and autoimmune diseases, announced that the company will present at the upcoming Morgan Stanley 2020 Virtual Asia Pacific Conference and ZGC Forum.

Report Highlights Efforts to Diversify Company, Conduct Unconscious Bias Training and to Hire People with Disabilities

Funding to support advancement of powerful bispecific gamma-delta T cell engager programs for the treatment of a broad range of cancers

Bioprocess is defined as a technique used to produce biological products such as genetically microbial strain and commercially useful chemicals.

The cryogenic biobanking services market may climb the growth ladder across the forecast period of 2020-2030 on the back of the growing demand for storing varied biological samples such as organs, human blood, cells, and tissues.

Disposable plastic syringes were introduced as an alternative to glass hypodermic needles.